Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study
Hereditary gelsolin (AGel) amyloidosis is an autosomal dominantly inherited systemic amyloidosis that manifests with the characteristic triad of progressive ophthalmological, neurological and dermatological si...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Eeva-Kaisa Schmidt, Tuuli Mustonen, Sari Kiuru-Enari, Tero T. Kivel รค and Sari Atula Tags: Research Source Type: research
More News: Amyloidosis | Brain | Dermatology | Finland Health | Internal Medicine | Neurology | Opthalmology | Rare Diseases | Skin | Study